发明名称 |
Therapeutic use of hemoglobin for preserving tissue viability and reducing restenosis |
摘要 |
Administration of low doses of hemoglobin minimizes damage to the myocardium after blockage and significantly reduces reperfusion injury. Hemoglobin exerts a pharmacological effect by increasing perfusion and blocking the molecular events leading to permanent injury following an ischemic episode. Additional benefits include a reduction in the number of post-ischemic arrhythmias, reduction in the incidence of restenosis, and improved contractile function in the area of risk.
|
申请公布号 |
US6458762(B1) |
申请公布日期 |
2002.10.01 |
申请号 |
US19940350204 |
申请日期 |
1994.12.02 |
申请人 |
BAXTER INTERNATIONAL, INC. |
发明人 |
MCKENZIE JACK E.;BURHOP KENNETH E. |
分类号 |
A61K38/42;(IPC1-7):A61K38/16;A61K35/14 |
主分类号 |
A61K38/42 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|